ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DELORISE BROWN M.D.

Endocrinology, Diabetes Metabolism

12,465

$875K

408
259 are 65+

20%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 47%

$70
Average prescription price

Avg: $148

DEEPAK SARWAL M.D.

Endocrinology, Diabetes Metabolism

12,266

$823K

339
272 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 47%

$67
Average prescription price

Avg: $148

M JAWADI M.D

Endocrinology, Diabetes Metabolism

11,596

$1.16M

790
548 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 47%

$100
Average prescription price

Avg: $148

LEROY SCHROEDER M.D.

Endocrinology, Diabetes Metabolism

10,892

$1.28M

733
586 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 47%

$117
Average prescription price

Avg: $148

HAROLD PRETORIUS M.D.

Endocrinology, Diabetes Metabolism

8,396

$800K

330
187 are 65+

13%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 47%

$95
Average prescription price

Avg: $148

MARCO CORALLO D.O.

Endocrinology, Diabetes Metabolism

8,394

$1.21M

598
458 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 47%

$144
Average prescription price

Avg: $148

IRINA KORABLEVA MD

Endocrinology, Diabetes Metabolism

8,098

$787K

751
572 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 47%

$97
Average prescription price

Avg: $148

ARVIND KRISHNA MD

Endocrinology, Diabetes Metabolism

7,968

$1.12M

889
697 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 47%

$141
Average prescription price

Avg: $148

ADRIAN SCHNALL M.D.

Endocrinology, Diabetes Metabolism

7,446

$598K

394
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 47%

$80
Average prescription price

Avg: $148

CYNTHIA DORSEY MD

Endocrinology, Diabetes Metabolism

6,811

$925K

659
489 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 47%

$136
Average prescription price

Avg: $148

NAILA GOLDENBERG MD

Endocrinology, Diabetes Metabolism

6,721

$715K

321
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 47%

$106
Average prescription price

Avg: $148

ANANT JEET MD

Endocrinology, Diabetes Metabolism

6,619

$902K

551
320 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 47%

$136
Average prescription price

Avg: $148

JOHN BRUNNER M.D.

Endocrinology, Diabetes Metabolism

6,553

$1.12M

644
508 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 47%

$171
Average prescription price

Avg: $148

RALPH WIELAND M.D.

Endocrinology, Diabetes Metabolism

6,508

$377K

222
209 are 65+

9%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 47%

$58
Average prescription price

Avg: $148

IAN ELLIOT MD

Endocrinology, Diabetes Metabolism

6,467

$787K

514
409 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 47%

$122
Average prescription price

Avg: $148

TIMOTHY WILLIAMS MD

Endocrinology, Diabetes Metabolism

6,302

$850K

627
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 47%

$135
Average prescription price

Avg: $148

KEVIN WIETECHA DO

Endocrinology, Diabetes Metabolism

6,145

$599K

853
691 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 47%

$98
Average prescription price

Avg: $148

RICHARD BEHAM M.D.

Endocrinology, Diabetes Metabolism

5,826

$1.14M

589
453 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 47%

$195
Average prescription price

Avg: $148

JOHN LARRIMER M.D.

Endocrinology, Diabetes Metabolism

5,801

$664K

579
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 47%

$115
Average prescription price

Avg: $148

DIANE TALLO M.D.

Endocrinology, Diabetes Metabolism

5,720

$864K

447
391 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 47%

$151
Average prescription price

Avg: $148

JAMES MYERS M.D.

Endocrinology, Diabetes Metabolism

5,717

$1.03M

496
400 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 47%

$181
Average prescription price

Avg: $148

JILL FELDER MD

Endocrinology, Diabetes Metabolism

5,712

$935K

509
317 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 47%

$164
Average prescription price

Avg: $148

MORTIMER DOLMAN M.D.

Endocrinology, Diabetes Metabolism

5,685

$666K

262
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 47%

$117
Average prescription price

Avg: $148

JOHN SEIDENSTICKER MD

Endocrinology, Diabetes Metabolism

5,410

$643K

360
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 47%

$119
Average prescription price

Avg: $148

CHARLES SMITH MD

Endocrinology, Diabetes Metabolism

5,340

$525K

418
335 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 47%

$98
Average prescription price

Avg: $148

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank